MétaCan
Menu
Back to cohort

Statins and the risk of idiopathic venous thromboembolism

2003· letter· en· W1501805006 on OpenAlexaff
Joel G. Ray, Muhammad Mamdani

Bibliographic record

VenueBritish Journal of Clinical Pharmacology · 2003
Typeletter
Languageen
FieldMedicine
TopicVenous Thromboembolism Diagnosis and Management
Canadian institutionsInstitute for Clinical Evaluative SciencesUniversity of Toronto
Fundersnot available
KeywordsMedicineStatinOdds ratioVenous thromboembolismInternal medicineDiseaseThrombosis

Abstract

fetched live from OpenAlex

The matched case–control study by Yang, Jick and Jick was designed ‘to evaluate the association between current statin use and the risk of idiopathic venous thromboembolism (VTE)’[1]. We feel obligated to address three points that challenge their most tenuous conclusion that ‘current statin use was not associated with a reduced risk of idiopathic VTE’. As shown in the Figure, the authors identified a total of 72 cases with idiopathic VTE, of whom only 37 (51%) had records confirming objectively proven VTE. The remaining 35 cases (49%) (dashed boxes) had ‘probable VTE’, of whom 22 individuals (30%) had no manual records available for review, but an ‘anticoagulant-supported diagnosis’ of idiopathic VTE [1]. Therefore, between 30% and 49% of the 72 cases may have been incorrectly classified as having VTE. Such nondifferential misclassification of disease status always introduces a bias toward the null value for the effect size [2]. Second, out of 72 cases with idiopathic VTE, only three (4.2%) were current or recent statin users, while 18 out of 432 controls (4.2%) were statin users, as listed in Table 2 of their paper [1]. Considering that only 4.2% of cases were exposed to statins, one cannot address the primary study question in a valid manner. At a rate of statin exposure of only 4.2% among the 432 controls, with a 6 : 1 matching of controls to cases, the statistical power was only 8% to demonstrate a statistically significant odds ratio (OR) of 0.5, for example. To show an OR of 0.9, as in their study [1], the corresponding power level was only 5%. Suppose that 8.4% of controls received statins, and there was a 50% reduction in the risk of VTE with statin use (i.e. OR 0.5). Using a case–control study with a 6 : 1 matching ratio, and with α= 0.05 and a conventional power setting of 80%, 373 cases and 2238 controls would be required, a sample size more than five times larger than that used in the current study [1]. Unfortunately, nowhere in their paper do the authors reveal a sample size estimation, or the fact that their study was severely underpowered. Finally, we previously published a retrospective cohort study of statin use and the risk of deep vein thrombosis (DVT) among 125 862 adults aged ≥ 65 years [3]. This study was initiated without knowledge of the findings of the Heart and Estrogen/progestin Replacement Study (HERS) [4]. After adjusting for age, sex, prior hospitalization, newly diagnosed cancer, or prescribed ASA, warfarin or oestrogen, we observed that statin users had an adjusted hazard ratio of 0.78 (95% confidence interval 0.69, 0.87) for DVT relative to those prescribed neutral thyroid replacement agents. This was evident in women but not men [3], supporting the findings of the HERS investigators [4]. Valid evidence is needed to address the hypothesis that statins may be protective against VTE [5]. Yang and colleagues may have arrived at a spuriously negative conclusion based on a suboptimal study design.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Commentary · Consensus signal: none
Teacher disagreement score0.003
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.005
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.033
GPT teacher head0.363
Teacher spread0.330 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2003
Admission routes1
Has abstractyes

Explore more

Same venueBritish Journal of Clinical PharmacologySame topicVenous Thromboembolism Diagnosis and ManagementFrench-language works237,207